HOOKIPA Pharma Inc. (NASDAQ:HOOK – Get Free Report)’s share price dropped 0% during mid-day trading on Tuesday . The company traded as low as $1.01 and last traded at $1.01. Approximately 526 shares traded hands during trading, a decline of 94% from the average daily volume of 8,102 shares. The stock had previously closed at $1.0101.
HOOKIPA Pharma Price Performance
The stock’s 50-day moving average is $0.96 and its 200 day moving average is $0.91. The stock has a market cap of $12.31 million, a price-to-earnings ratio of -0.17 and a beta of 0.92.
About HOOKIPA Pharma
HOOKIPA Pharma Inc is a clinical-stage biotechnology company focused on the development of virus-based immunotherapies and vaccines. The company operates two complementary platform technologies—an engineered Modified Vaccinia Ankara (MVA) vector and an arenavirus vector system—designed to stimulate both humoral and cellular immune responses. By combining these platforms, HOOKIPA aims to address infectious diseases and drive novel immuno-oncology treatments.
In the infectious disease arena, HOOKIPA’s pipeline includes prophylactic vaccine candidates targeting pathogens such as cytomegalovirus (CMV) in transplant settings and other viral threats.
Recommended Stories
- Five stocks we like better than HOOKIPA Pharma
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This makes me furious
Receive News & Ratings for HOOKIPA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HOOKIPA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
